Art

J-GLOBAL ID：201902241880959780   Reference number：19A1323912

Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial

日本における高リスク虚血性脳卒中患者の二次予防のためのシロスタゾールを用いた二重抗血小板療法:多施設オープンラベル無作為化対照試験【JST・京大機械翻訳】

Author (16)： Toyoda Kazunori (Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Centre, Osaka, Japan) ,  Uchiyama Shinichiro (Clinical Research Centre for Medicine, International University of Health and Welfare, Tokyo, Japan) ,  Uchiyama Shinichiro (Centre for Brain and Cerebral Vessels, Sanno Hospital and Sanno Medical Centre, Tokyo, Japan) ,  Yamaguchi Takenori (Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Centre, Osaka, Japan) ,  Easton J Donald (Department of Neurology, University of California, San Francisco, CA, USA) ,  Kimura Kazumi (Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan) ,  Hoshino Haruhiko (Department of Neurology, Tokyo Saiseikai Central Hospital, Tokyo, Japan) ,  Sakai Nobuyuki (Department of Neurosurgery, Kobe City Medical Centre General Hospital, Kobe, Japan) ,  Okada Yasushi (Clinical Research Institute and Department of Cerebrovascular Medicine and Neurology, National Hospital Organisation Kyushu Medical Centre, Fukuoka, Japan) ,  Tanaka Kortaro (Department of Neurology, University of Toyama, Toyama, Japan) ,  Origasa Hideki (Division of Biostatistics and Clinical Epidemiology, University of Toyama, Toyama, Japan) ,  Naritomi Hiroaki (Department of Neurology, Senri Chuo Hospital, Toyonaka, Japan) ,  Houkin Kiyohiro (Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan) ,  Yamaguchi Keiji (Department of Neurology, Ichinomiya Nishi Hospital, Ichinomiya, Japan) ,  Isobe Masanori (Department of Neurosurgery, Kushiro Rosai Hospital, Kushiro, Japan) ,  Minematsu Kazuo (Headquarters of the Iseikai Medical Corporation, Osaka, Japan)
Material： Lancet Neurology
Volume： 18  Issue： 6  Page： 539-548  Publication year： 2019 
JST Material Number： W3105A  ISSN： 1474-4422  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Although dual antiplatelet the...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1323912&from=J-GLOBAL&jstjournalNo=W3105A") }}

Thesaurus term： *therapy ,  effectiveness ,  *cerebral apoplexy ,  safety ,  risk factor ,  hemorrhage ,  recurrence ,  *randomized controlled trial ,  administration(biology) ,  *human(primates) ,  fatty acid ,  aromatic carboxylic acid ,  phenolic compound ,  carboxylate(ester) ,  hydroxy acid ,  alicyclic compound ,  lactam ,  phenol ether ,  polynuclear aromatic compound
Semi thesaurus term： 有害事象 ,  危機的出血 ,  *抗血小板療法 , 【Automatic Indexing@JST】

JST classification (3)： Nervous system diseases  (GN03000O) ,  Basic neurology  (GN01020W) ,  Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Substance index (3)： Clopidogrel ,  Aspirin ,  Cilostazol

Terms in the title (10)： 日本 ,  リスク ,  虚血性脳卒中 ,  患者 ,  二次予防 ,  シロスタゾール ,  抗血小板療法 ,  施設 ,  ラベル ,  無作為化対照試験